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Abstract
dce” is a form of rnethamnhetamThe common/v used
as a recreational drug in Hawaii and the Philippines,
but seldom encountered in the continental United
States. It differs in appearance from methamphec
amine tablets, but otherwise has exactly the same
molecules, only arranged in a crystalline structure. A
sibeable boo’y of in vitro, animal, and autopsy data
suggest a linkage between methamphetamine use
andmyocardial pathology. In this report, we describe
a series of eight patients who developed unstable
angina or acute myocardial infarction in association
with smoking crystal metbarriohetamine. The findings,
to a large extent, resemble those with cocainmassoci
ated acute coronary syndromes. Given the wide
spread abuse of methamphetamine among young
age groups. the recognition and primary prevention of
cardiovascular toxic effects is of mounting socioeco
nomic importance.
Introduction
Stimulation of central nervous system by metham
phetarnine leads to a multitude of psychohehavioral
manifestations including euphoria, increased energy
and self-confidence, and enhanced sexuality. I rritahil
ity, insomnia and, when taken in vary large quantities,
impaired judgment are its unwanted effects, Acute
toxicity may also lead to irrational and violent behav
ior, delerium, paranoia, hallucinations, homicide or
suicide, “ With chronic use, irreversible structural
brain damage may occunii Many of the symptoms
produced resemble those produced by cocaine use,
though it is not clearwhetherthe same mechanisms are
involved, Very little is known about metham
phetamine’s ability to initiate or exacerbate acute
coronary syndromes. In this report we describe a series
of eight patients who developed unstable angina or
acute myocardial infarction in association with smok
ing of crystal methamphetami ne.
Methods and Results
The study was approved by the local institutional
review committee, We retrospectively collected de
mographic and clinical data on eight crystal metham
phetamine users, All had been admitted to a tertiary
care center in Honolulu, Hawaii, for treatment ofacute
coronary syndrome, during the period from April
1997 to July 2000, None ofthe patients had any history
of prior myocardial infarction, valvular heart disease,
cardiac surgery, and all denied ever having used
cocaine or heroin, The patient characteristics are de
scribedin table I, Their mean age was 37 years (range
23-449 All patients admitted recurrent abuse of “ice”,
the smokable form of methamphetamine and denied
intravenous administration, The specifics of metham
phetamine exposure are described in table 2,
Four ofthe eight patients (50%) had for ST-segment
elevation myocardial infarction, while 3 of 8 (38%)
and I of 8(12%) were diagnosed with non-ST-seg.
ment elevation myocardial infarction and unstable
angina respectively, The clinical characteristics of
their acute coronary syndromes are described in table
Table 4 describes the investigational findings in this
cohort, Of the 6 patients who underwent cardiac
catheterization, 5 were shown to have obstructive
coronar artery disease with the remaining patient
having clean coronary’ arteries, Two patients refused
invasive management .A 11 patients survived the index
hospitalization and were discharged home in stable
condition,
Discussion
In this case series, we report eight patients who
developed acute coronary syndromes in association
with the smoking of crystal methamphetamine. The
features of this cohort — young age group, predomi
nant representation of native Hawaiian ethnicity and
universal use of “ice” as the mode of drug used
represent the general characteristics of a methamphet
amine user in Hawaii, Their presentations represented
the entire spectrum of acute coronary syndromes,
including unstable angina, non- ST elevation myocar
dial infarction and ST elevation myocardial infarc
tion, Of the 6 patients who underwent coronary an
giography, 5 had evidence for significant obstructive
epicardial coronary artery disease, In 2 patients, find
ings suggestive of coronary vasospasm or small vessel
disease were present, as demonstrated by a normal
coronary angiogram in one patient and a normal
nuclear my’ocardial perfusion study’ in another patient.
A survey of the English medical literature reveals
onl 1 5 similar case reports of myocardial infarction
,l1cvui, tt’jiefw;vg ff1)
B
associated with the use of amphetamine related corn
pounds.1-A summary of previously published case
reports is show n in table 5. By contrast. the literature
is replete with cases of acute rnvocardial infarction
after cocaine use.
Dun no the past 15 sears, the use ot methamphet—
amine has increased dramatically in Ha au, the Pa
cific coast and the southfmid west of the United
States. The .uUu National Household Survey on Dnic
Abuse estimated that .8 million Americans useul
merhamphetamine intheirlife time. This tigure shows
a marked increase from the I 994 estimate of 3.3
million. In comparison, 23,8 mil lion Americans had
used cocaine in their life time 2’,’
Met hamphetarnine is the N—methyl homologue of
amphetamine (figure I ). It is a white, odorless, bitter,
crystalline powder that is soluble in water and alco
hol.2’ It can he smoked, snorted, ingested or injected
intravenously. The preferred route of methamphet
amine administration varies among geographical re
gions A report in 1997 showed that 92% ofmetham
phetamine users in Honolulu preferred the smokable
form compared to 32% in San Diego and 11% in San
Francisco. The predominant mode of methamphet
amineadministratton in San Diego was sniffing 38%
w here as in San Francisco n was intravenous injec
tions (57%
Methamphetamine is called by many names, in
cluding “crank”. “speed”, “tweak”, “go-fast”, “go”.
“glass”. “crystal meth”, “ens” or “cnistv”. “Ice” is a
common street name in Hawaii for crystal metham—
phetarnine, and is named for its resemblance to chunks
of translucent glass Among the Filipino expatriate community in Hawaii. crystal
methamphetamine has been known as “ham”, meaning “rock” in Tagalog Ian—
ouaoe.2
.-\mplietarnine related compounds exert their physiolo ical effects predomi—
nanth by releasing catecholamine neurotransmitters torm the adrenal medulla and
the nerve terminals. This leads to increased le els of circulating carecholamines
and the stimulation of central and peripheral alpha and beta adrenerg’ic receptors.
Table 1.
— Patient Characteristics
Traditional
Patient Number Age Gender Ethnicity Cardiac Risk Significant Past
Factors Medical History
1 35/NI Fortugese HTN n.one
2 34/F Caucasian HTN, lob, HC none
3 40/M Hawaiian Tob, HC, FH none
4 44/F Japanese HTN none
S 23M Caucasian none none
dru” n dH 43M Fhoino HTN Tab
. psychoss
7 38T Hawauan Tab none
S 39FF Hawaiian HTN Tob HO none
Mmale, F4emale, HTNhypertension. Tobat least 5 pack year tobacco smoking,
HChypercholesterolemia (total cholesterol >23OmgIdl)
Table 2.
— Sp itt s of Methamphetamine Exposure
Patient Number Verification Type Current Abuse Frequency Duration Last Dose Alcohol Other
I Hx Ice Yes NR 9 yrs 2 hrs Yes No
2 Hx Ice Yes NH NH NH No No
3 Hx ce Yes 1..•’wk Smo I2hrs Yes No
0 2oO’ cc ‘es ‘-20K ‘ Vs No
5 ‘ cc “es NH NH Nc \o
‘
005 cc Yes r-2ok NH 05 ha No No
‘ cc No N NP ‘ ‘-c Yes
S. Hx,Utox cc Nes NH NH 2 sos No No
Hxtpatient history, Utoxurine toxicology, wkweek. yrsyears, mo=months, hrshours, NRnot recorded, Last dosez intake time prior to presentation to the hospital,
Alcoholconcurrent alcohol use per history, Othei= concurrent use of other recreational drugs than methamphetamine per history or urine drug screening
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Table 3 — Chnical Characteristics
Patient Presenting Symptom Cardiac Injury Markers
.
Vital Signs at Presentation Electrocardiographic Changes at PresentationNumber Symptims Duration Maximum Recored
T BP HR CK CKMB cTnl
cr.’c0-aa.es
avs’ea a.—
2 8 hours 98A 105118 60 ST-segment &evation in leads aVL. V2%5 5756 80 150
3 Chest pain 6 hours 98.0 140190 100 ST-seament depression in add 14-6 1638 193 1.30
—
ST-sea-’er aenesson :n
—
‘- — — — — —
— —
— snen I
7 Chest pain 2 hours 96.7 170/120 77 ST-segment elevation in ieads 12-14 1087 NR NR
8 Ch.est pain 2 hours 98.5 202.•125 92 7-wave inversions in leads V2-V6 145 10 4.8
NRnot recorded, Thtemperature (in F). BPrblood pressure (in mmHg). HRheart rate (beats per minute), CKcreatine kinase (normal range 10-70 U(L),
CKMBcreatine kinase MB fraction (normal range 0-7 microglL). cTnl=cardiac troponin I (normal range 0-0.4 microgIL)
Table 4. — investigational Findings
Patient Number Catheterization Thrombolytics Angiographic Findngs
Echocardiography Perfusion
r ad 70% lesion in oroximal RCA: distal No
NWM, NO
.
...
.
oocius/o f circumflex (Altemotedl LVEF 651:1
50% ewon n prç,:m AL. 70%
2 ‘es “es n aoxma hrst aagorah ..VE 43% NP NP
I r C — — —
3 Yes No 90% lesion in proxim:ai first diagonal Yes LVIII
artehor wa/i
4 No No No NP NP NP
—
‘-
—
‘-
7 Yes No 90%
ooclusicn of proximal LAD: No LIE 58% NPhypoenesls of antenor walr (Attempted)
8 No No No NP NP
RCAtright coronary artery, LADleft anterior descending artery, LVEFleft ventricular ejection fraction, NPnot performed NWMnormal wall motion
—
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Table 5. — Summary of cases of myocardial infarction associated with amphetamine related compounds. previously published in the English
medical literature.
Ref. Number Age (Yrs)IGender Agent, Dose and Route of Administration
Coronary Arteries per
4 49/F metararnol,IV moutes NR
5 22W cropylhexedrine PC severa hours NP
9 14:W amphetamne. PC 3-4 months normal
7 58,1st dexlroamphetamme, PC possibly hours NP
8 22F amrhetamme V 10 hours normal
5 24W amphetamine 20-50 mo IV 5 hours norn’ai
10 334v1 amphetamine. 60 mg, IV 1 hour normal
11 41 M crvsta methamphetamme ‘ntranasal 1 1 ‘2 hours Mid RCA thrombus
2 27W amphatamine 1 5 cm. IV 4 hours normal
13 31/F crystal methamphetamine, intranasal NP normal’
14 37/F amphetamme, IV NP normal
15 42M amphetamine intranasal 20 minutes NR
16 29/F amphetamme. PC NR prox. LAD
17 35/NI methamphetamme. intranasal hours 90% prox.
18 31W amphetamme 4 dO55 IV 8 hours NP
* perautopsy, MMale, FFemale, NR=Not Recorded, POPeroraI, IV=lntravenous, RCA= Right Coronary Artery, Prox. LAD Proximal Left Anterior Descending Artery
Thus, there is a fundamental similarity between the
effects of amphetamines, cocaine and other states
characterized by high circulating levels of catechola
mine. In addition, amphetamines increase the cat
echolamine levels in the synaptic cleft by inhibiting
the enzyme monoamine oxidase in the nerve termi
nals24 Amphetamines may al so have a direct stimu
lating effect on end organs.25
The intake ofamphetamine related compounds com
monlv leads to cardiovascular manifestations such as
tachycardia, chest pain and Inperrension.’ At higher
doses tachyarrhsthmias have been described,35’7Sev
eral case reports have previously ascribed amphet
amines also to a multitude of cardiac and vascular
pathology including cardiomvopathv’3’2acute
pulmonary edemai’45’necrotizing vascuIitis.42en
docarditis, pulmonary hypertension,” aortic dis
sectio&”5’cerebral arteritis,52 ischemic stroke ortran
sient ischemic attacks.5354 cerebrovascular hemor
rhage’55and sudden cardiac death.45’’”
Autopsy studies have shown that premature and
multivessel coronary artery disease occurs at a much
higher rate in methamphetamine users than in age-
matched controls,5°Based upon animal studies, some
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authors have postulated that the increase in circulating
catecholamine levelsproduced by amphetamines could
enhance coronary tone and aggregation of platelets,
leading to thrombus formation and acute vascular
occlusion. Animal studies have also suggested
the possibility of diffuse myocardial inflammation
and necrosis inducedhvhigh carecholamme levels.”
In the hitherto published cases (including the current
case series), of 16 patietvs w ho under ent coronary
angiography or autopsy 50% (8 of 16) had normal
coronary arteries while the other 50% (8 of l6 had
evidence of single or multivessel disease. Hence, the
occurrence of acute coronary syndrome in the setting
of methampheramine exposure. raises the possibility
of rupture of a vulnerable atherosclerotic plaque and;
or extensive coronary vasospasnL’ resembling the
acute myocardial tschemia observed in cocaine users.
Despite the observed association between met ham
phetamine use, development of premature atheroscle
rosis and induction of acute coronary syndromes,
several issues remain unsolved and need to he ad
dressed.
1) Although the rationale for such an association
seems intuitive, current data on this subject are
li mitedto individual clinical observations. Hence
despite a compelling case. current data do not
indisputablyestahlish a causal link between meth
amphetamine use and acute coronary syndromes.
Recent studies have shown that contamination
of illicit methamphetarnine with chloroephedrine,
other organic compounds and heavy metals may
have toxic consequences.’69Future case-con
trol studies may minimizepotential comorhidities
andor confounders and examine this associa
tion more elaborately.
2) Despite apparent resemblance in pathophysiol
og. methamphetamine related mvocardial inf
arction is far less commonly observed than co
caine related myocardial infarction. While this
could he due to lower incidence of methamphet
amine use comparedro cocaine use in the popula
tion, inadequate histoty taking, incomplete drug
screening and underreporting by health care pro
viders may also account for the difference in
prevalence ofthese t o conditions. Recent stud
ies on experimental animals have also Provided
insights into molecular biological disparities he
tw een amphetamine and cocaine. Amphetamine,
when compared with cocaine, leads to a greater
degree of induction of myocardial heat shock
proteins. With more heat shock proteins in the
cytoplasm. mvocvtes become more resistant to
stressorssuchasischemia and in1urv. (‘onse—
quenrly, methamphetanune may cause less’ mvo—
cardial damage than cocaine,58
3 Recent evidence also suggests that met hamphet
amine exposure is associated with the develop
ment of dilated cardiomvopathy even in the
absence ofobstructive coronary artervdisease.’
Possible explanations for the development of
dilated cardiomvopathy in these patients in
clude small vessel disease, recurrent coronary
vasospasm or direct mvocardial toxicity due to
chronic methamphet amine intake. Ho ever, the
exact pathophysiologic mechanisms leading to
the manifestation of dilated cardiomvopathy
with methamphetamine exposure remain to he
elucidated.
4 The current treatment strategy of methamphet—
amine related acute coronary syndrome largely
derives from our current understanding of the
treatment of this condition in the general popu
lation. If coronar vasospasm is consideredto be
a cause. the use of beta adrenergic blockers may
he contraindicated. as it may lead to unopposed
alpha adrenergic receptor stimulation and wors
ening of vasospasm. In this setting. a non
dihydropyridine calcium-channel blocker and
aspirin may provide a useful therapeutic combi
nation.’ Along the lines of recent trials empha
sizing the superiority of invasive therapy as
opposed tothromholvtic therapvin acute myocar
dial infarction detiningthe coronary anatomy
is likely to be the strategy of choice for
reperfusion in patients present with metham
phetamine associated acute coronary syndromes.
Last, hut not least, the active involvement of
psychiatric and social services with the aim of
prevention, rehabilitation and abstinence from
crystal methamphetamine use should he the cor
ner stone in the management of these patients.
Limitations of Study
Like all observational studies, this case series has
certain limitations. Only half of the individuals in—
chided in this study underwent drug screening, so
other drugs may have gone undetected, and it is
possible that the clinical course of these individuals
could have been modified by their prior use of other
recreational drugs. The actual doses taken are not
kno n ith certaint and blood concentrations ‘ crc
not recorded in any of the cases. so the course of the
symptoms cannot be related to merhamphetamine’s
pharmacokinetic effects As in all observational stud
ies, conclusions about causality cannot be drawn with
certainty, in addition the patients were not followed up
prospectively and data on long-term prognosis are not
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Conclusion
Several layers of evidence suggest that methamphet—
amine use is associated with the development of
cardiovascular pathology, including accelerated ath
erosclerosis and premature acute coronary syndromes.
Our observations suggest that crystal methamphet
amine is associated with acute coronary syndrome in
some patients. Given the n idespread abuse of meth—
amphetamine amonc vounc ace croups. the recogni
tion and primary prevention ot cardiovascular toxic
effects is of mounting socioeconomic importance.
Increasing the awareness of the public and of the
health care providers about the catastrophic cardio
vascular consequences of methamphetamine use is
imperative. It is also important to pursue further re
search in to elucidating pathophvsiological mecha
nisms and developing mana ement strategies.
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Classified Notices
To place a classified notice:
HMA members—Please send a signed and type
written ad to the HMA office. As a benefit ot member
ship. HMA members may place aco-mplimentarv one
time classified ad in HMJ as space N available.
Nonmembers,—Please call 536-7702 for a non-
member form. Rates are $1.50 a word with a minimum
of 20 words or $30. Not commissionable. Payment
must accompany written order,
Units for Sale
AIEA MEDICAL BUILDING 2 ,JOLTS AVA]LABE
SALE UnrI #205 offered at $102,000 Co rESBsa ft
#206 offered at 6’ ‘3000 LH 1698sq.ft.) Buy each un-rI senor
rate]y ortogetne- Oar. Vnce Vanderatroorn. RAtormore rYc
and ahowings cP 778-0065/947-8112.
Seeking Position
ANESTHESIOLOGIST — LOOK1NG FOR POSITION. Soc
ciaHnterestPa]nMananement.25yearsexperienceinFann’Iy
Medicine 5 years enperi900e in Anesthesroiogy. Pn-ET
Inquir]es by c-marl at dkosre@yaboo.com.au,
Aloha Laboratories, Inc.
I’hen results count
A CAP accredited laboratory
specializing in Anatomic
Pathology
Quality and Service
David M. Am berger. M.D.
Laboratory Director
Phone: (808) 832-6600
Fax: (808) 848-0663
F—Mail: rcsults’vi alohalabs.coni
hItp:i/s t.a1oha1ahs.coinIn cii 111,2 SiflOlitoril ìl rim’ ‘ecu iii tire I l:imajj Medical J,’rurnal,
1” piaec a a’laSsitied ad call 536—7702.
23
